ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 132 filers reported holding ANAPTYSBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,235,355 | -11.7% | 124,463 | 0.0% | 0.06% | -30.0% |
| Q2 2023 | $2,531,577 | +0.7% | 124,463 | +7.8% | 0.08% | +3.9% |
| Q1 2023 | $2,512,823 | -99.9% | 115,479 | +41.4% | 0.08% | +92.5% |
| Q3 2022 | $2,083,000,000 | +26.7% | 81,668 | +0.9% | 0.04% | +66.7% |
| Q2 2022 | $1,644,000,000 | – | 80,966 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
| EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
| GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
| Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
| Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
| Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
| Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
| Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
| TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
| Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |